Barclays raised the firm’s price target on Waystar (WAY) to $50 from $42 and keeps an Overweight rating on the shares. The company reported better than expected Q4 revenue and EBITDA margin, with revenue driven by higher than seasonal patient payments, the analyst tells investors in a research note. The firm says Waystar’s fiscal 2025 revenue guidance is going up, and if normalized for early revenue starts, would be inline with its low-double-digit growth framework.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAY:
- Waystar Holding Corp. Receives Buy Rating Amid Strong Q4 Performance and Growth Potential
- Waystar Holding Corp. Shows Strong Fiscal Growth in 2024
- Waystar’s Strong Q4 Earnings Highlight Record Growth
- Waystar files to sell 18M shares of common stock
- Waystar price target raised to $50 from $42 at RBC Capital